You are using an unsupported browser. This web site is designed for the current versions of Microsoft Edge, Google Chrome, Mozilla Firefox, or Safari.
The Office of the Federal Register publishes documents on behalf of Federal agencies but does not have any authority over their programs. We recommend you directly contact the agency associated with the content in question.
If you have comments or suggestions on how to improve the www.ecfr.gov website or have questions about using www.ecfr.gov, please choose the 'Website Feedback' button below.
If you would like to comment on the current content, please use the 'Content Feedback' button below for instructions on contacting the issuing agency
Enhanced content is provided to the user to provide additional context.
This content is from the eCFR and is authoritative but unofficial.
Navigate by entering citations or phrases (eg: 1 CFR 1.1 49 CFR 172.101 Organization and Purpose 1/1.1 Regulation Y FAR).
Choosing an item from citations and headings will bring you directly to the content. Choosing an item from full text search results will bring you to those results. Pressing enter in the search box will also bring you to search results.
Background and more details are available in the Search & Navigation guide.
The in-page Table of Contents is available only when multiple sections are being viewed.
Use the navigation links in the gray bar above to view the table of contents that this content belongs to.
This content is from the eCFR and may include recent changes applied to the CFR. The official, published CFR, is updated annually and available below under "Published Edition". You can learn more about the process here.
Subscribe to: 21 CFR 600.15
No changes found for this content after 1/03/2017.
View the most recent official publication:
These links go to the official, published CFR, which is updated annually. As a result, it may not include the most recent changes applied to the CFR. Learn more.
Information and documentation can be found in our developer resources.
The Code of Federal Regulations (CFR) is the official legal print publication containing the codification of the general and permanent rules published in the Federal Register by the departments and agencies of the Federal Government. The Electronic Code of Federal Regulations (eCFR) is a continuously updated online version of the CFR. It is not an official legal edition of the CFR.
Learn more about the eCFR, its status, and the editorial process.
The following products shall be maintained during shipment at the specified temperatures:
(a) Products.
| Product | Temperature |
|---|---|
| Cryoprecipitated AHF | −18 °C or colder. |
| Measles and Rubella Virus Vaccine Live | 10 °C or colder. |
| Measles Live and Smallpox Vaccine | Do. |
| Measles, Mumps, and Rubella Virus Vaccine Live | Do. |
| Measles and Mumps Virus Vaccine Live | Do. |
| Measles Virus Vaccine Live | Do. |
| Mumps Virus Vaccine Live | Do. |
| Fresh Frozen Plasma | −18 °C or colder. |
| Liquid Plasma | 1 to 10 °C. |
| Plasma | −18 °C or colder. |
| Platelet Rich Plasma | Between 1 and 10 °C if the label indicates storage between 1 and 6 °C, or all reasonable methods to maintain the temperature as close as possible to a range between 20 and 24 °C, if the label indicates storage between 20 and 24 °C. |
| Platelets | Between 1 and 10 °C if the label indicates storage between 1 and 6 °C, or all reasonable methods to maintain the temperature as close as possible to a range between 20 to 24 °C, if the label indicates storage between 20 and 24 °C. |
| Poliovirus Vaccine Live Oral Trivalent | 0 °C or colder. |
| Poliovirus Vaccine Live Oral Type I | Do. |
| Poliovirus Vaccine Live Oral Type II | Do. |
| Poliovirus Vaccine Live Oral Type III | Do. |
| Red Blood Cells (liquid product) | Between 1 and 10 °C. |
| Red Blood Cells Frozen | −65 °C or colder. |
| Rubella and Mumps Virus Vaccine Live | 10 °C or colder. |
| Rubella Virus Vaccine Live | Do. |
| Smallpox Vaccine (Liquid Product) | 0 °C or colder. |
| Source Plasma | −5 °C or colder. |
| Source Plasma Liquid | 10 °C or colder. |
| Whole Blood | Blood that is transported from the collecting facility to the processing facility shall be transported in an environment capable of continuously cooling the blood toward a temperature range of 1 to 10 °C, or at a temperature as close as possible to 20 to 24 °C for a period not to exceed 6 hours. Blood transported from the storage facility shall be placed in an appropriate environment to maintain a temperature range between 1 to 10 °C during shipment. |
| Yellow Fever Vaccine | 0 °C or colder. |
(b) Exemptions. Exemptions or modifications shall be made only upon written approval, in the form of a supplement to the biologics license application, approved by the Director, Center for Biologics Evaluation and Research.
[39 FR 39872, Nov. 12, 1974, as amended at 49 FR 23833, June 8, 1984; 50 FR 4133, Jan. 29, 1985; 50 FR 9000, Mar. 6, 1985; 55 FR 11013, Mar. 26, 1990; 59 FR 49351, Sept. 28, 1994; 64 FR 56449, Oct. 20, 1999]